Standard dose 131 I therapy for toxic multinodular goiter in an endemic goiter region

• Autor(a) principal: Gonçalves, E.
• Data de Publicação: 1986
• Outros Autores: Castro, Jose Augusto Sisson de, Gross, Jorge Luiz
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/247375
• topic: Bócio endêmico; Tireotoxicose; Toxic multinodular goiter; 131 I therapy; Thyrotoxicosis

1. The effect of the standard 15 mCi dose of 131 I on the thyroid function of 25 patients from an endemic goiter region with toxic multinodular goiter of different sizes was determined. 2. The patients were followed for 1 to 5 years and 7 months (mean: 2 years and 10 months). Eighteen patients were treated with the antithyroid drugs propylthiouracil or methimazole before 1 3 1 I and seven only received 131 I. 3. All but three patients achieved euthyroidism after a single dose of 131 1. Two patients in the antithyroid treatment group became hypothyroid 2 months and 2 years after the isotope therapy, respectively. Pretreatment with antithyroid drugs did not significantly modify the effectiveness of 131 I treatment. 4. This simplified dose regimen of 131 I was effective in the treatment of hyperthyroidism caused by multinodular goiter in an endemic region, and the efficacy was independent of the size of the goiter.